Connect with us

Education & Research

Plant Medicine

Published

on

In Grass Roots America Magazine, we discuss plant medicines and the science surrounding their uses, along with stories about the people’s lives they affect. Our previous issue featured interviews with U.S. Army Veteran, Matt Kahl, and Dr. Sue Sisley. Matt shared about his positive experience with ayahuasca, and how it helped with his PTSD. Dr. Sisley, the world’s leading researcher on cannabis and PTSD in veterans, also discussed how she’s heard reports of veterans feeling better and more joyful after going on their own journey with things like psilocybin, ayahuasca, and/or ibogaine. In addition to our interviews, the GRAM team attended the 2019 Cannabis Science Conference West in Portland, OR, where Olivia Newton John explained how cannabis helped her get off morphine and how ayahuasca allowed her to quit taking antidepressants.

In addition to these powerful testimonials, psychedelic legal reform is continuing to progress around the country. In 2019, Denver became the first major city to decriminalize psilocybin possession and personal use for those ages 21 and above. A month later, Oakland became the second major city to decriminalize psilocybin, as well as other psychedelics that come from plants and fungi, including ayahuasca, ibogaine, and peyote. Supporters share how they found the plants helpful for overcoming trauma, depression, addiction, and anxiety. This psychedelic movement is advancing quickly with Portland, Dallas, Chicago, and Berkeley proposing to decriminalize some sort of psychedelic plants. 

It’s a priority to share these new discoveries.

Even scientific research in the United States is beginning to rapidly expand as people become more interested in the possibility of psychedelic therapies becoming a natural option for medical treatment. In the fall of 2019, a group of private donors gave $17 million dollars to start a Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine. “Johns Hopkins is deeply committed to exploring innovative treatments for our patients,” says Paul B Rothman, Dean of the Medical Faculty at the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine. “Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential.” 

Inspired by our interviews, the progression of decriminalizing natural plant medicines like cannabis, psilocybin, and ayahuasca throughout the U.S., and the advances of plant medicine research, we feel it’s a priority to share these new discoveries. This is why we’re beginning this plant medicine column, which will be featured every month, leading up to an entire issue focused on all plant medicines, later this year. Plant medicine topics we will cover will include things like cannabis and psychedelics, but also how different plant foods work as a medicine, the health benefits of things like essential oils, and more. If it’s a natural medicine that comes from plants, we’ll cover it here, because we are dedicated to delivering Great Research About Medicine, one GRAM at a time, with informative material empowering you to take control of your health and well-being.

Continue Reading
Advertisement

Education & Research

What’s Working for Stress Issues

Published

on

Releaf is a free mobile app that encourages patients to mindfully track their cannabis experiences. They believe you will strengthen your relationship with yourself while also learning how cannabis can help alleviate your specific issues and ailments. GRAM is proud to share with our readers data gathered using Releaf from individuals suffering from stress symptoms. 

They reported the effectiveness of products for specific symptoms of individuals suffering from anxiety, insomnia, agoraphobia, depression, PTSD, and gastrointestinal problems. The data reflect their individual experiences self-reported using the Releaf App.


Top Rated in USA

Anxiety

  • Orange Cream, Concentrate | The Clear | Colorado
  • Zen Pure Reserve Oil, Concentrate | Surterra | Florida
  • Ac/Dc, Flower | Opc Cultivation | Ohio

Insomnia

  • Grape Dreams, Concentrate | Evolab | Colorad
  • Cherry Chem Og, Concentrate | Ascend Illinois | Illinois
  • 707 Headband Live Resin Budder, Concentrate | Cresco | Pennsylvania

Agoraphobia

  • Orange Cream, Concentrate | The Clear | Colorado
  • Zen Pure Reserve Oil, Concentrate | Surterra | Florida
  • Purple Haze #44, Wax | Prime Wellness | Pennsylvania


Depression

  • Flo, Flower | Emerald Fields | Colorado
  • Zen Pure reserve Oil | Surterra | Florida
  • Florida Black Haze #14, Flower | Prime Wellness | Pennsylvania

PTSD

  • Flo, Flower | Emerald Fields | Colorado
  • Holy Roller Og, Flower | Bold | Arkansas
  • Terra Penn Wife’s Poison, Concentrate | Terrapin | Pennsylvania

Gostrointestinal Problems

  • Jillybean, Flower | Baseball 18 | Colorado
  • Lemon G, Flower | Terrapin | Pennsylvania
  • Harmony, Concentrate | Luxlyte | New York

Top Rated in Florida

Anxiety

  • Zen Pure Reserve Oil, Concentrate | Surterra
  • Ac/Dc, Concentrate | Trulieve
  • Super Sour Diesel, Concentrate | Trulieve

Insomnia

  • Granddaddy Purple, Concentrate | Curaleaf
  • 9lb Hammer, Concentrate | Trulieve
  • Vidacann Indica, Pill | Vidacann

Agoraphobia

  • Zen Pure Reserve Oil | Surterra
  • Ac/Dc, Concentrate | Trulieve
  • Suer Sour Diesel, Concentrate | Trulieve

Depression

  • Zen Pure Reserve Oil | Surterra
  • Ac/Dc, Concentrate | Trulieve
  • Super Sour Diesel, Concentrate | Trulieve

PTSD

  • Ac/Dc, Concentrate | Trulieve
  • Super Sour Diesel, Concentrate | Organic Smart Cart
  • Jack Herer, Concentrate | Curaleaf

Gastrointestinal Problems

  • Zen, Concentrate | Surterra
  • Serene Blend, Concentrate | Surterra
  • Revive AM Blend, Concentrate | Surterra

DOWNLOAD RELEAF APP TODAY TO TRACK, LEARN FROM, AND IMPROVE YOUR USE OF CANNABIS BY VISITING: releaf.at/GRAM

Continue Reading

Scientists & Researchers

Dr. Salm Live Interview

Published

on

In case you missed the live video from our friends at Nugtopia, here it is! Jordan Person from Gram Magazine interviews Dr. Salm, a cannabis scientist that lived at an Antarctic Research station for 3 months! Covering terpenes, isolation and more…

Nugtopia 3 Pm

Jordan Person from Gram Magazine and Dr. Salm a cannabis scientist that lived at an Antarctic Research station for 2 years!

Posted by Tom Quigley on Monday, April 20, 2020

Continue Reading

Scientists & Researchers

Russo’s Research

Published

on

Dr. Russo comments in his latest editorial how the medical community has failed to appropriately manage chronic conditions such as pain and other debilitating diseases.

“The National Academies of Sciences, Engineering, and Medicine opined in 2017 that “there is conclusive or substantial evidence that cannabis or cannabinoids are effective: for the treatment of chronic pain in adults.”2

 Russo states that we need to face the facts:

– What doctors are currently using (opioids and non-opioids) is not effective in managing patients’ symptoms, and the lack of willingness tof many medical professionals to consider other options leaves the patients suffering.

– There is no longitudinal data that shows the efficacy of using opioids long term for chronic noncancer pain, and there is not much being developed in the drug market that aims to make any difference in how we currently treat patients.

 – Whether anyone likes it or not, increasingly millions of people around the globe are utilizing cannabis to treat their pain, and observational studies and surveys repeatedly demonstrate that pain is the top medical indication for cannabis usage, in the range of 70% of all patients.5

– No medication is deemed commercially successful unless the patient reports clinical improvements and perceives that they are improving due to the drug.

– There truly is no way to take an objective measurement of pain in the clinical field.

In order for anything in the medical/ biotechnology field to be taken seriously, there needs to be a randomized, double-blind placebo study with results that can be easily replicated and that is why cannabis has not been taken seriously for its therapeutic benefits. Due to the schedule 1 nature it makes it extremely difficult for researchers to do double-blind placebo studies. There is so much red tape on the subject that we are left with anecdotal evidence from patients along with the few clinical trials that are available using Sativex, the synthetic version of a 1:1 THC CBD oral mucosal spray.

Continue Reading

Trending